Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2016

To view an abstract, select an author from the vertical list on the left.

2016 Grants - Kuruppu

A Venom Derived Peptide to Treat Alzheimer’s Disease

Sanjaya Kuruppu, Ph.D.
Monash University
Clayton, Australia

2016 Alzheimer’s Association Research Grant (AARG)

Can a molecule found in snake venom help reduce the build-up of beta-amyloid in the brain during Alzheimer’s disease?

In Alzheimer’s disease, beta-amyloid protein fragments can accumulate to form “plaques” in the brain — a hallmark feature of the disease. Specific proteins in healthy brain cells can recognize and remove potentially harmful beta-amyloid before it forms plaques. Improving the function of these proteins could be a novel way to reduce beta-amyloid accumulation in the brain and potentially slow or halt the progression of Alzheimer’s disease.

Research Plan
Sanjaya Kuruppu, Ph.D. and colleagues have identified a small protein, or peptide, in snake venom that stimulates two processes responsible for removing potentially harmful beta-amyloid from brain cells. In their initial studies, the snake venom peptide slowed beta-amyloid build-up in nerve cells grown in laboratory dishes, and in the brains of a small test group of Alzheimer’s-like mice.

For their current studies, Dr. Kuruppu’s team will test and validate the effects of the snake venom peptide using a larger number of Alzheimer’s-like mice. The researchers will make chemical modifications to the peptide and test several different forms to determine which types may be able to reduce beta-amyloid levels and improve cognitive function in the Alzheimer’s-like mice.

This study could provide new information about how beta-amyloid accumulates in the brain during Alzheimer’s disease. If successful, results of this work could provide the foundation for the development of snake venom peptides as a potential therapy to slow or prevent the progression of Alzheimer’s disease.

Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.